Table 1.
Summary of basal characteristics of 137 patients with pancreatic neuroendocrine tumors at time of diagnosis and follow-up.
| Subjects (%) | Median (IQR) | |
|---|---|---|
| Females | 75 (56%) | |
| Males | 62 (44%) | |
| Age (years) | 61 (50-71) | |
| Size (cm) | 2 (1.3-5) | |
| Stage n=137 | ||
| Tx, unknown | 7 (5%) | |
| T 1, <2 cm limited to the pancreas | 64 ((47%) | |
| T 2, 2-4 cm limited to the pancreas | 9 (7%) | |
| T 3, > 4 cm limited to the pancreas | 35 (26%) | |
| T 4, invading adjacent organs | 22 (16%) | |
| MEN-1 | 15 (11%) | |
| Functioning | 30 (22%) | |
| Surgery | 101 (74%) | |
| Total pancreaectomy | 4 (3%) | |
| Whipple | 28 (19%) | |
| Partial resection | 60 (44%) | |
| Enucleated | 6 (4%) | |
| Liver procedure | 3 (2%) | |
| Re-operated | 11 (11%) | |
| Conservatively (no surgery initially) | 36 (26%) | |
| Surgery at a later stage | 2 (4%) | |
| Follow-up time (months) | 74 (41-110) | |
| Deceased | 26 (19%) | |
| Age at death (years) | 73 (66-78) | |
| Age at Pan-NET death (years) | 75 (66-76) |
IQR, interquartile range; MEN-1, multiple endocrine neoplasia; Pan-NET, pancreatic neuroendocrine tumor.